Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSONAL-pilot: Tamsulosin N-of-1 for LUTS
NCT05415748Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamsulosin in benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), sponsored by University of California, San Francisco. Started Sep 2021; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT05415748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05415748.